PDE Studies

Secure, password-protected access to certified PDE determination strategies and toxicological assessments for active pharmaceutical ingredients.

Available Protected Studies

Select any study below to access full toxicological data and digital verification.

Protected Study

Mometasone Furoate

Topical Application

PDE Determination Strategy for Mometasone Furoate (Topical) with full toxicological basis and digital verification.

Company: SAMARRA / IRAQ
Assessment Date: March 2026
PDE Value: 3 µg/person/day
Version: 1.0

Protected Study

N-acetyl cysteine

Oral Administration

PDE Determination Strategy for N-acetyl cysteine (Oral) with full toxicological assessment and digital verification.

Company: SDI (SAMARRA / IRAQ)
Assessment Date: June 2026
PDE Value: 50 mg/person/day
Version: 1.0

Protected Study

Levetiracetam

Oral Administration

PDE Determination Strategy for Levetiracetam (Oral) with full toxicological assessment and digital verification.

Company: SDI (SAMARRA / IRAQ)
Assessment Date: June 2026
PDE Value: 1.25 mg/person/day
Version: 1.0